Keywords: Alendronate; bone mineral density; osteoporosis; risedronate; treatment failure;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Monolithic materials; In-needle extraction; Polymer-ceramic materials; Risedronate; Organophosphates; Hydroxyapatite;
Keywords: Osteoporosis; Risedronate; Rat model; Zinc-hydroxyapatite; Nanomedicine
Keywords: Alendronate; Risedronate; Osteoporosis/drug therapy; Male; Off-label useÁcido alendrónico; Ácido risedrónico; Osteoporosis/tratamiento farmacológico; Varón; Uso fuera de ficha técnica
Keywords: mandibular fracture; haematoma; bisphosphonate; alendronate; risedronate; osteogenic activity
Keywords: 2-DE; two-dimensional gel electrophoresis; ECL; enhanced chemiluminescence; FBS; fetal bovine serum; FPPS; farnesyl pyrophosphate synthase; IPP; isopentyl diphosphate; LC; liquid chromatography; MALDI-ToF; matrix-assisted laser desorption/ionization-time
Keywords: ALP; alkaline phosphatase; BP; bisphosphonate; FPPS; farnesyl pyrophosphate synthase; Irf8; interferon regulatory factor 8; MafB; V-maf musculoaponeurotic fibrosarcoma oncogene homolog B; MFI; median fluorescence intensity; ONJ; osteonecrosis of the jaw;
Keywords: Minodronate; Osteoporosis; Risedronate
Star-shaped poly(oligoethylene glycol) copolymer-based gels: Thermo-responsive behaviour and bioapplicability for risedronate intranasal delivery
Keywords: Nasal delivery; Thermo-responsive star-shaped polymers; Risedronate; Thermogel; Cytocompatability; Antiosteoporotic activity;
Poly(vinyl alcohol)/hydroxyapatite Monolithic In-Needle Extraction (MINE) device: Preparation and examination of drug affinity
Keywords: Monoliths; In-needle extraction; Polymer-ceramic materials; Bisphosphonate; Risedronate;
Hydroxyapatite functionalization to trigger adsorption and release of risedronate
Keywords: Bisphosphonate; Risedronate; Hydroxyapatite; Poly-ethylenimine; Zinc; Adsorption; Release;
Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
Keywords: Bisphosphonates; Alendronate; Risedronate; Zoledronic acid; Denosumab; Drug holiday;
Anti-osteoporosis effects of 1,4-dihydroxy-2-naphthoic acid in ovariectomized mice with increasing of bone density
Keywords: Osteoporosis; DHNA; Ovariectomized mice; Bone resorption; Risedronate
Estudio PERSIRIS: estudio observacional, postautorización, prospectivo, para evaluar la persistencia al tratamiento con risedronato mensual en mujeres con osteoporosis
Keywords: Osteoporosis; Persistencia terapéutica; RisedronatoOsteoporosis; Medication persistence; Risedronate
Risedronate adsorption on bioactive glass surface for applications as bone biomaterial
Keywords: Adsorption; Bisphosphonate; Bioactive glass; Risedronate; Spectroscopy;
Bioactive glass combined with bisphosphonates provides protection against biofilms formed by the periodontal pathogen Aggregatibacter actinomycetemcomitans
Keywords: Aggregatibacter actinomycetemcomitans; Bisphosphonates; Bioactive glass; Periodontitis; Risedronate; Dental biofilms
Reduced food interaction and enhanced gastrointestinal tolerability of a new system based on risedronate complexed with Eudragit E100: Mechanistic approaches from in vitro and in vivo studies
Keywords: Risedronate; Eudragit E; Complex; Bioavailability enhancement; Gastric damage; Food interaction
Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: Pharmacokinetic and biochemical assessment
Keywords: NP; Nanoparticle; BPs; Bisphosphonates; GIT; Gastro intestinal tract; HA; Hydroxyapatite; PLGA; Poly(lactide-co-glycolide); ODDS; Osteotropic drug delivery systems; AA; Ascorbic acid; GP; β-glycerophosphate; ALP; Alkaline Phosphatase; TRAP; Tartrate resi
Prescripción de ácidos alendrónico y risedrónico en varones: uso fuera de la ficha técnica en un área de salud
Keywords: Ácido alendrónico; Ácido risedrónico; Osteoporosis/tratamiento farmacológico; Varón; Uso fuera de ficha técnica; Alendronate; Risedronate; Osteoporosis/drug therapy; Male; Off-label use;
Stimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3
Keywords: Angiogenesis; Risedronate; 1,25(OH)2D3; 24,25(OH)2D3;
The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells
Keywords: Bisphosphonates; Cell cycle; DBF4; Invasion assay; Risedronate; Zoledronate;
Novel Pullulan–Eudragit® S100 blend microparticles for oral delivery of risedronate: Formulation, in vitro evaluation and tableting of blend microparticles
Keywords: Pullulan; Eudragit S100; Microparticles; Blending; Risedronate; Oral delivery
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
Keywords: Denosumab; Postmenopausal osteoporosis; Risedronate; Bone mineral density; Bone turnover markers;
Efficacy, tolerability and safety of once-monthly administration of 75Â mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5Â mg once-daily dosage regimen
Keywords: Bisphosphonates; Bone mineral density; Involutional osteoporosis; Risedronate; Lumbar spine;
Infrared, Raman and NMR investigations of risedronate adsorption on nanocrystalline apatites
Keywords: BP, bisphosphonate; NCA, nanocrystalline apatite; HA, well crystallised stoichiometric hydroxyapatiteAdsorption; Bisphosphonate; Hydroxyapatite; Nanocrystalline apatite; Risedronate; Spectroscopy
Risedronate increases osteoblastic differentiation and function through connexin43
Keywords: Connexin43 (Cx43); Risedronate; Osteoblast;
Farsenyl pyrophosphate synthase is a potential molecular drug target of risedronate in Babesia bovis
Keywords: Babesia bovis; Risedronate; Farnesyl pyrophosphate synthase
Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation
Keywords: Risedronate; Adipogenesis; Bone marrow fat; Osteoclast; Receptor activator of nuclear factor-κB ligand; Osteoprotegerin
Risedronate Positively Affects Osteogenic Differentiation of Human Mesenchymal Stromal Cells
Keywords: Mesenchymal stromal cell; Osteoblast differentiation; Adipocyte differentiation; Risedronate; Osteoporosis
Evidence for safety and efficacy of risedronate in men with osteoporosis over 4Â years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
Keywords: Bisphosphonates; Bone mineral density; Bone turnover markers; Male osteoporosis; Risedronate;
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate
Keywords: ZOL; Zoledronic Acid; RIS; Risedronate; BMD; Bone Mineral Density; LS; Lumbar Spine; TH; Total Hip; FN; Femoral Neck; GIO; Glucocorticoid-induced Osteoporosis; HORIZON; Health Outcomes and Reduced Incidence with zoledronic Acid ONce yearly; P1NP; Procolla
Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model
Keywords: Risedronate; Topical delivery; Osteoporosis; Ovariectomized mouse model;
Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC–MS/MS) for determination of risedronate concentrations in human plasma
Keywords: Risedronate; Bisphosphonate; Liquid chromatography/tandem mass spectrometry (LC–MS/MS); Trimethylsilyldiazomethane; Derivatization; Solid phase extraction (SPE); Plasma; Quantification
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
Keywords: Bisphosphonates; Bone metastases; Castration Resistant Prostate Cancer; Docetaxel; Risedronate;
Risedronate improves bone mineral density in Crohn's disease: A two year randomized controlled clinical trial
Keywords: Crohn's disease; Bisphosphonate; Risedronate; Osteoporosis; Osteopenia;
Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover
Keywords: Bisphosphonates; Alendronate; Risedronate; Osteoporosis; Bone turnover;
Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate
Keywords: Teriparatide; Alendronate; Risedronate; Bone material properties; Fourier transform infrared imaging; Raman Microspectroscopy; Mineral maturity; Collagen cross-links;
Bisphosphonates for postmenopausal osteoporosis
Keywords: Osteoporosis; Alendronate; Ibandronate; Clodronate; Zoledronic acid; Risedronate;
Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice
Keywords: Bisphosphonate; Risedronate; Mechanical loading; Functional adaptation; Osteoporosis;
Dose-dependent differential effects of risedronate on gene expression in osteoblasts
Keywords: Bisphosphonate; Risedronate; Osteoblast; Gene; Bone
Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin
Keywords: Risedronate; Bisphosphonate; Ion pairs; Transdermal delivery
Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
Keywords: IPP, isopentenyl pyrophosphate; ApppI, triphosphoric acid 1-adenosin-5′-yl ester 3-(3-methylbut-3-enyl) ester; FPPS, farnesyl pyrophosphate synthaseBisphosphonate; Risedronate; Zoledronate; FPPS; Angiogenesis
Bisphosphonates in phenytoin-induced bone disorder
Keywords: Alendronate; Ibandronate; Risedronate; Phenytoin; Homocysteine; Bone demineralization
Characterization of a New Solvate of Risedronate
Keywords: risedronate; bisphosphonates; osteoporosis; polymorphism; crystal structure; crystallization; hydrates/solvates; X-ray diffractometry; dissolution;
Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting
Keywords: Risedronate; Surface engineer; Microspheres; Pulmonary; Osmogen
Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading
Keywords: Alendronate; Risedronate; Zoledronate; Ulna loading; Ovariectomy
Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures
Keywords: Bone mineral density; Bone resorption; Low back pain; Osteoporosis; Risedronate; Vertebra
Outcome of Patients With Early Breast Cancer Receiving Nitrogen-Containing Bisphosphonates: A Comparative Analysis From the Metropolitan Detroit Cancer Surveillance System
Keywords: Alendronate; Ibandronate; MDCSS; Risedronate
Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: A longitudinal study
Keywords: Risedronate; Pulse wave velocity; Intima-media thickness; Bone mineral density; Atherosclerosis; Osteoporosis
Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenopausal Women With Type 2 Diabetes Mellitus Accompanied With Osteoporosis
Keywords: Risedronate; Alfacalcidol; Atherosclerosis; Type 2 diabetes mellitus; Osteoporosis;